The uveo-meningeal syndromes

Neurologist

Volumn 10, Issue 4, 2004, Pages 171-184

  Brazis, Paul W ^a   Stewart, Michael ^a   Lee, Andrew G ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Choroiditis; Meningitis; Retinitis; Uveitis; Uveo meningeal syndrome; Vitritis

Indexed keywords

AUTOIMMUNE DISEASE; BEHCET DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; MENINGOENCEPHALITIS; MENINX; MENINX DISORDER; OPTIC NERVE DISEASE; PIGMENT DISORDER; PRIORITY JOURNAL; RETINA; RETINITIS; REVIEW; SARCOIDOSIS; UVEA; UVEA DISEASE; UVEITIS; UVEOMENINGEAL SYNDROME; VOGT KOYANAGI SYNDROME; WEGENER GRANULOMATOSIS;

HUMANS; MENINGITIS; RETINITIS; SYNDROME; UVEITIS;

EID: 3242720388     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000131145.26326.ff     Document Type: Review

References (84)

1. Moorthy RS, Rao NA. Uveitis: introduction and classification. In: Wright KW, ed. Textbook of Ophthalmology. Baltimore, MD: Williams and Wilkins; 1997:477-479.
2. Forster DJ. General approach to the Uveitis patient and treatment strategies. In: Yanoff M, Duker JS, eds. Ophthalmology. London: Mosby; 1999:3
3. Moorthy RS, Rao NA. Approach to the uveitis patient. In: Wright KW, ed. Textbook of Ophthalmology. Baltimore, MD: Williams and Wilkins; 1997:481-486.
4. Henderly DE, Gensler AJ, Smith RE, et al. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131-136.
5. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593-599.
6. Brazis PW, Lee AG. Optic disk edema with a macular star. Mayo Clin Proc. 1996;71:1162-1166.
7. Cohen SM, Davis JL, Gass DM. Branch retinal arterial occlusions in multifocal retinitis with optic nerve edema. Arch Ophthalmol. 1995;113:1271-1276.
8. Golnik KC, Marotto ME, Fanous MM, et al. Ophthalmic manifestations of Rochalimaea species. Am J Ophthalmol. 1994;118:145-151.
9. Solley WA, Martin DF, Newman NJ, et al. Cat scratch Disease. Posterior segment manifestations. Ophthalmology. 1999;106:1546-1553.
10. Wong MT, Dolan MJ, Lattuada CP Jr., et al. Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type I. Clin Infect Dis 1995;21:352-360.
11. Knox DL, Bayless TM, Yardley JH, et al. Whipple's disease presenting with ocular inflammation and minimal intestinal symptoms. Johns Hopkins Med J. 1968;123:175-182.
12. Finelli PF, McEntree WJ, Lessell S, et al. Whipple's disease with predominantly neuro-ophthalmologic manifestations. Ann Neurol. 1977;1:247-252.
13. Font RL, Rao NA, Issarescu S, et al. Ocular involvement in Whipple's disease: light and electron microscopic observations. Arch Ophthalmol 1978;96:1431-1436.
14. Leland TM, Chambers JK. Ocular findings in Whipple's disease. South Med J. 1978;71:335-338.
15. Avila MP, Jalkh AE, Feldman E, et al. Manifestations of Whipple's disease in the posterior segment of the eye. Arch Ophthalmol. 1984;102:384-390.
16. Rickman LS, Freeman WR, Green WR, et al. Brief report: uveitis caused by Tropheryma Whippelii (Whipple's Bacillus). New Engl J Med. 1995;332:363-366.
17. Schwartz MA, Harris JK, Campbell WW, et al. Oculomasticatory myorhythmia: a sign of Whipple's disease. Ann Neurol. 1985;18:135-136.
18. Schwartz MA, Selhorst JB, Ochs AI, et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986;20:677-683.
19. Louis ED, Kusske JA, Rush JL, et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996;46:561-568.
20. Park SS, To KW, Friedman AH, et al. Infectious causes of posterior uveitis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, PA: WB Saunders;1994:453-454.
21. Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol. 1993;38:229-256.
22. Jabbour NM, Faris B, Trempe CL. A case of pulmonary tuberculosis presenting with a choroidal tuberculoma. Ophthalmology. 1985;92:834-837.
23. Kent SJ, Crowe SM, Yung A, et al. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993;17:987-994.
24. Berile GR, Flynn TE. Syphilis exposure in patients with uveitis. Ophthalmology. 1997;104:1605-1609.
25. Ho AC, Guyer DR, Yannuzzi LA, et al. Ocular syphilis. Classic manifestations and recent observations. Semin Ophthalmol. 1993;8:53-60.
26. Yagasaki T, Akiyama K, Nomura H, et al. Two cases of acquired syphilis with acute central choroiretinitis as initial manifestation. Jpn J Ophthalmol. 1992;36:301-309.
27. Anderson M. Management of cerebral infection. J Neurol Neurosurg Psychiatr. 1993;56:1243-1258.
28. Steere AC. Lyme disease. New Engl J Med 321;586-596, 1989.
29. Jacobson DM, Frens DB. Pseudotumor cerebri syndrome associated with Lyme disease. Am J Ophthalmol. 1989;107:81-82.
30. Aaberg TM. The expanding ophthalmologic spectrum of Lyme disease. Am J Ophthalmol. 1989;107:77-80.
31. Breeveld J, Kuiper H, Spanjaard L, et al. Uveitis and Lyme borreliosis. Br J Ophthalmol. 1993;77:480-481.
32. Bialasiewicz AA, Ruprecht KW, Naumann GOH, et al. Bilateral diffuse choroiditis and exudative retinal detachment with evidence of Lyme disease. Am J Ophthalmol. 1988;105:419-420.
33. Kuiper H, Koelman JH, Jager MJ. Vitreous clouding associated with Lyme borreliosis. Am J Ophthalmol. 1989;108:453-454.
34. Winterkorn JMS. Lyme disease: neurologic and ophthalmic manifestations. Surv Ophthalmol. 1990;35:191-204.
35. Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Int Med. 1989;149:2226-2228.
36. Menezes AV, Sigesmund DA, Demajo WA, et al. Mortality of hospitalized patients with Candida endophthalmitis. Arch Int Med. 1994;154:2093-2097.
37. Donohue SP, Eller AW. Intraocular Candida infection. Semin Ophthalmol. 1993;8:70-76.
38. Moorthy RS, Sidikaro Y, Foos RY, et al. Coccidioidomycosis iridocyclitis. Ophthalmology. 1994;101:1923-1928.
39. Rodenbiker HT, Ganley JP. Ocular coccidioidomycosis. Surv Ophthalmol. 1980;24:263-290.
40. Crumo JR, Elner SG, Elner VM, et al. Cryptococcal endophthalmitis: case report and review. Clin Infect Dis. 1992;4:1069-1073.
41. Garrity JA, Herman DC, Imes R, et al. Optic nerve sheath decompression for visual loss in patients with Acquired Immunodeficiency Syndrome and Cryptococcal meningitis with papillederna. Am J Ophthalmol. 1993;116:472-478.
42. Denning DW, Armstrong RW, Fishman M, et al. Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. Rev Infect Dis. 1991;13:1126-1130.
43. Weingeist TA, Watzke RC. Ocular involvement by Histoplasma capsulatum. Int Ophthalmol Clin. 1983;23:33-47.
44. Specht CS, Mitchell KT, Bauman AE, et al. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome. Ophthalmology. 1991;98:1356-1359.
45. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseinated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis, and treatment, and review of the literature. Medicine. 1990;69:361-374.
46. Gottleib JL, McAllister IL, Guttman FA, et al. Choroidal blastomycosis: a report of two cases. Retina. 1995;15:248-252.
47. Safneck JR, Hogg GR, Napier LB. Endophthalmitis due to Blastomyces dermatitidis. Case report and review of the literature. Ophthalmology. 1990;97:212-216.
48. Bradsher RW. Blastomycosis. Clin Infect Dis. 1992;14(Suppl 1):S82-S90.
49. Harding CV. Blastomycosis and opportunistic infections in patients with acquired immunodeficiency syndrome. Arch Path Lab Med. 1991;115:1133-1166.
50. Graham DA, Kinyuon JL, George DP. Aspergillus endophthalmitis after lung transplantation. Am J Ophthalmol. 1995;119:107-109.
51. Valluri S, Moorthy RS, Rao NA. Endogenous Aspergillus endophthalmitis in an immunocompetent individual. Int Ophthalmol. 1993;17:131-135.
52. Shirouzu K, Hasuo K, Yasumori J, et al. MR imaging in paranasal and intracranial aspergillosis. Nippon Acta Radiol. 1991;51:768-774.
53. Ronday MJH, Luyendijk L, Baarsma GS, et al. Presumed acquired ocular toxoplasmosis. Arch Ophthalmol. 1995;113:1524-1529.
54. Moreno RJ, Weisman J, Waller S. Neuroretinitis: an unusual presentation of ocular toxoplasmosis. Ann Ophthalmol. 1992;24:68-70.
55. th Edition. Baltimore, MD: Williams and Wilkins; 1998:4500-4503.
56. th Edition. Baltimore, MD: Williams and Wilkins; 1998:4945-5360.
57. Newman NJ, Slamovits TL, Friedland S, et al. Neuro-ophthalmic manifestations of meningocerebral inflammation form limited form of Wegener's granulomatosis. Am J Ophthalmol. 1995;120:613-621.
58. th Edition. Baltimore, MD: Williams and Wilkins; 1998:3725-3886.
59. Nishino H, Rubino FA, DeRemee RA, et al. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33:4-9.
60. Specks U, Moder KG, McDonald TJ. Meningeal involvement in Wegener granulomatosis. Mayo Clin Proc. 2000;75:856-859.
61. Obenauf CD, Shaw HE, Sydnor CF, et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648-655.
62. Silver MR, Messner LV. Sarcoidosis and its ocular manifestations. J Am Optom Assoc. 1994;65:321-327.
63. th Edition. Baltimore, MD: Williams and Wilkins; 1998:5465-5538.
64. Sharma OP, Sharma AM. Sarcoidosis of the nervous system: a clinical approach. Arch Int Med. 1991;151:1317-1321.
65. Wakefield D, McCluskey P. Behçet's syndrome: ocular features in an Australian population. Aust NZ J Ophthalmol. 1990;18:129-135.
66. Shimuzu T, Ehrlich GE, Inaba G, et al. Behçet's disease. Semin Arth Rheum. 1979;8:223-260.
67. Kansu T. Neuro-Behçet's Disease. The Neurologist. 1998;4:31-39.
68. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35.
69. Ohno S, Char DH, Kimura SJ, et al. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977;83:735-740.
70. Perry HD, Font RL. Clinical and histopathological observations in severe Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1977;83:242-254.
71. Reed RW, Rao NA, Cunningham ET Jr. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol. 2000;11:437-442.
72. Gass JDM. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80:177-185.
73. Bullock JD, Fletcher RL. Cerebrospinal fluid abnormalities in Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1977;84:45-49.
74. Comu S, Verstraeten T, Rinkoff JS, et al. Neurologic manifestations in Acute posterior multifocal placoid pigment epitheliopathy. Stroke. 1996;27:996-1001.
75. Kersten DH, Lessel S, Carlow TJ. Acute posterior multifocal placoid pigment epitheliopathy and late onset menigoencephalitis. Ophthalmology. 1987;84:393-396.
76. Comu S, Verstraeten T, Rinkoff JS, et al. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke. 1996;27:996-1001. Deleted in Proof.
77. th Edition. Baltimore, MD: Williams and Wilkins; 1998:2329-2436.
78. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100:1399-1406.
79. Peterson K, Gordon KB, Heinemann MK, et al. The clinical spectrum of orbital lymphoma. Cancer. 1993;72:843-849.
80. Lachance DH, O'Neill BP, Macdonald DR, et al. Primary leptomenigeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology. 1991;41:95-100.
81. Leys AM, Van Eyck LM, Nuttin BJ, et al. Metastatic carcinoma to the retina. Clinicopathologic findings in two cases. Arch Ophthalmol. 1990;108:1448-1452.
82. Spraul CW, Martin DF, Hagler WS, et al. Cytology of metastatic cutaneous melanoma to the vitreous and retina. Retina. 1996;16:328-332.
83. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49:146-154.
84. Cross S. A paraneoplastic syndrome of combined optic neuritis and retinitis defined serologically by CRMP-5-IgG [Abstract]. J Neuro-Ophthalmol. 2002;22:169.